Status:
COMPLETED
Corneal Collagen Cross-linking for Progressive Keratoconus
Lead Sponsor:
Glaukos Corporation
Conditions:
Progressive Keratoconus
Eligibility:
All Genders
14+ years
Phase:
PHASE3
Brief Summary
Prospective, randomized multicenter study to determine the safety and effectiveness of performing cornea collagen cross-linking (CXL) using riboflavin and UVA light in eyes with progressive keratoconu...
Detailed Description
This was a sham controlled study for the first three months. Patients had one eye designated as the study eye and were randomized to receive one of two study treatments (CXL or sham) in their study ey...
Eligibility Criteria
Inclusion
- Diagnosis of keratoconus
- Documented progression over previous 24 months
- Decreased BSCVA
- Must complete all study visits
Exclusion
- Prior corneal surgery or Intacs
- History of delayed wound healing
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT00647699
Start Date
December 1 2007
End Date
April 1 2011
Last Update
April 26 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Shiley Eye Center
La Jolla, California, United States, 92093
2
Gordon -Weiss Vision Institute
San Diego, California, United States, 91222
3
Center for Excellence in Eye Care
Miami, Florida, United States, 33176
4
Price Vision Group
Indianapolis, Indiana, United States, 46260